-
Posted by
Two Blokes May 28, 2025 -
Filed in
Stock
-
7 views
Orchestra BioMed holds two best-in-class medical device therapies targeting large markets, with strong partnerships and equity investments from Medtronic and Terumo. Both AVIM Therapy and Virtue SAB have received FDA Breakthrough Device Designations. Clinical data for both devices show best-in-class efficacy compared to standard of care and competitors, positioning them as potential standards of care.
